nejm retatrutide 2023年度回顧】 Notable Articles of 2023 Day 3: Triple–Hormone-Receptor Agonist for Obesity — A Phase 2 Trial. N Engl J Med 2023; 389:514-526. 製圖：Sardinosis Retatrutide Peptide: The Breakthrough Triple-Hormone
Description
Green tea is a gentle supporter not a medical weight loss drug
Several studies point to a protective role of GLP-1RAs on retinal pigment epithelium (RPE) cells, which form the blood-retinal barrier and are vulnerable to inflammation [83, 84]
doi: 10.3389/fendo.2019.00051 182 MieczkowskaAIrwinNFlattPRChappardDMabilleauG
This can make it a helpful option for athletes, travel, or situations where fluid needs may be higher
Tan HC et al
